The Real‐World Experience With Single Agent Ibrutinib in Relapsed/Refractory CLL
- Resource Type
- Article
- Authors
- Akpinar, Seval; Dogu, Mehmet Hilmi; Celik, Serhat; Ekinci, Omer; Hindilerden, Ipek Yonal; Dal, Mehmet Sinan; Davulcu, Eren Arslan; Tekinalp, Atakan; Hindilerden, Fehmi; Ozcan, Busra Gokce; Hacibekiroglu, Tuba; Erkurt, Mehmet Ali; Bagci, Metin; Namdaroglu, Sinem; Korkmaz, Gulten; Bilgir, Oktay; Cagliyan, Gulsum Akgun; Ozturk, Hacer Berna Afacan; Serin, Istemi; Tiryaki, Tarık Onur; Ozatli, Duzgun; Korkmaz, Serdal; Ulas, Turgay; Eser, Bulent; Turgut, Burhan; Altuntas, Fevzi
- Source
- In Clinical Lymphoma, Myeloma and Leukemia March 2022 22(3):169-173
- Subject
- Language
- ISSN
- 2152-2650